Bertolina, C. (2025) “Durable complete response in a patient with BRAF-mutated advanced melanoma with ocular and skin toxicities from BRAF/MEK targeted therapy after checkpoint inhibitor treatment: a case report”, Dermatology Reports, 18(1). doi:10.4081/dr.2025.10324.